Multistate Models to Predict Development of Late Complications of Type 2 Diabetes in an Open Cohort Study

References

• Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;8(4):228–236. doi:10.1038/nrendo.2011.183
   Web of Science ®Google Scholar
• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151
   PubMed Web of Science ®Google Scholar
• Chawla A, Chawla R, Jaggi S. Microvascular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab. 2016;20(4):546–551. doi:10.4103/2230-8210.183480
   PubMedGoogle Scholar
• Solomon SD, Chew E, Duh EJ, et al. Diabetic retinopathy: a Position Statement by the American Diabetes Association | diabetes Care. Available from: https://care.diabetesjournals.org/content/40/3/412.abstract. Accessed October 9, 2019.
   Google Scholar
• Kosiborod M, Gomes MB, Nicolucci A, et al. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol. 2018;17(1):150. doi:10.1186/s12933-018-0787-8
   PubMed Web of Science ®Google Scholar
• Moradi Y, Baradaran HR, Djalalinia S, et al. Complications of type 2 diabetes in Iranian population: an updated systematic review and meta-analysis. Diabetes Metab Syndr. 2019;13(3):2300–2312. doi:10.1016/j.dsx.2019.05.018
   PubMedGoogle Scholar
• Manaviat MR, Afkhami M, Shoja MR. Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmol. 2004;4(1):9. doi:10.1186/1471-2415-4-9
   PubMedGoogle Scholar
• Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–584. doi:10.1016/j.cjca.2017.12.005
   PubMed Web of Science ®Google Scholar
• Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5(3):150–159. doi:10.1038/ncpendmet1066
   PubMedGoogle Scholar
• Nentwich MM, Ulbig MW. Diabetic retinopathy - ocular complications of diabetes mellitus. World J Diabetes. 2015;6(3):489–499. doi:10.4239/wjd.v6.i3.489
   PubMed Web of Science ®Google Scholar
• Sabanayagam C, Wong TY. Diabetic Retinopathy and Cardiovascular Disease. Karger Medical and Scientific Publishers; 2019.
   Google Scholar
• IDF Diabetes Atlas 9th edition 2019. Available from: https://www.diabetesatlas.org/en/. Accessed April 25, 2020.
   Google Scholar
• Chatziralli IP, Sergentanis TN, Keryttopoulos P, Vatkalis N, Agorastos A, Papazisis L. Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. BMC Res Notes. 2010;3:153. doi:10.1186/1756-0500-3-153
   PubMedGoogle Scholar
• Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care. 2004;27(suppl1):s84–s87. doi:10.2337/diacare.27.2007.S84
   PubMedGoogle Scholar
• Basi S, Fesler P, Mimran A, Lewis JB. Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander? Diabetes Care. 2008;31(Supplement2):S194–S201. doi:10.2337/dc08-s249
   PubMedGoogle Scholar
• Currie GE, von Scholten BJ, Mary S, et al. Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria. Cardiovasc Diabetol. 2018;17(1):50. doi:10.1186/s12933-018-0697-9
   PubMedGoogle Scholar
• Bjerg L, Hulman A, Carstensen B, Charles M, Jørgensen ME, Witte DR. Development of microvascular complications and effect of concurrent risk factors in type 1 diabetes: a multistate model from an observational clinical cohort study. Diabetes Care. 2018;41(11):2297–2305. doi:10.2337/dc18-0679
   PubMedGoogle Scholar
• Van Den Hout A. Multi-State Survival Models for Interval-Censored Data. Chapman and Hall/CRC; 2016.
   Google Scholar
• Cook RJ, Lawless JF. Multistate Models for the Analysis of Life History Data. Chapman and Hall/CRC; 2018.
   Google Scholar
• Janghorbani M, Amini M. Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors. Diabetes Res Clin Pract. 2005;70(1):71–80. doi:10.1016/j.diabres.2005.02.017
   PubMedGoogle Scholar
• Goldenberg R, Punthakee Z. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes. 2013;37:S8–S11. doi:10.1016/j.jcjd.2013.01.011
   PubMed Web of Science ®Google Scholar
• Janghorbani M, Amini M, Tavassoli A. Coronary heart disease in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Acta Cardiol. 2006;61(1):13–20. doi:10.2143/AC.61.1.2005135
   PubMed Web of Science ®Google Scholar
• Koroshi A. Microalbuminuria, is it so important? Hippokratia. 2007;11(3):105–107.
   PubMedGoogle Scholar
• Hadi Alijanvand M, Aminorroaya A, Kazemi I, et al. Cross-sectional and longitudinal assessments of risk factors associated with hypertension and moderately increased albuminuria comorbidity in patients with type 2 diabetes: a 9-year open cohort study. Diabetes Metab Syndr Obes. 2019;12:1123–1139. doi:10.2147/DMSO.S189726
   PubMed Web of Science ®Google Scholar
• Jackson C. Multi-state models for panel data: the msm package for R. J Stat Softw. 2011;38(1):1–28. doi:10.18637/jss.v038.i08
   Google Scholar
• Titman AC. Computation of the asymptotic null distribution of goodness-of-fit tests for multi-state models. Lifetime Data Anal. 2009;15(4):519. doi:10.1007/s10985-009-9133-5
   PubMedGoogle Scholar
• Ishihara M, Yukimura Y, Aizawa T, Yamada T, Ohto K, Yoshizawa K. High blood pressure as risk factor in diabetic retinopathy development in NIDDM patients. Diabetes Care. 1987;10(1):20–25. doi:10.2337/diacare.10.1.20
   PubMedGoogle Scholar
• Bae EH, Lim SY, Han K-D, et al. Association between systolic and diastolic blood pressure variability and the risk of end-stage renal disease. Hypertension. 2019;74:HYPERTENSIONAHA–119.
   Google Scholar
• Eryd SA, Gudbjörnsdottir S, Manhem K, et al. Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study. BMJ. 2016;354:i4070. doi:10.1136/bmj.i4070
   PubMedGoogle Scholar
• Liu Y, Yang J, Tao L, et al. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ Open. 2017;7(9):e016280. doi:10.1136/bmjopen-2017-016280
   PubMed Web of Science ®Google Scholar
• Bathum L, Depont Christensen R, Engers Pedersen L, Lyngsie Pedersen P, Larsen J, Nexøe J. Association of lipoprotein levels with mortality in subjects aged 50 + without previous diabetes or cardiovascular disease: a population-based register study. Scand J Prim Health Care. 2013;31(3):172–180. doi:10.3109/02813432.2013.824157
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang C, Shi K, Yin X. Relationship between dyslipidemia and diabetic retinopathy. Medicine (Baltimore). 2018;97:36. doi:10.1097/MD.0000000000012283
   Google Scholar
• Ramanathan Amnath S. Correlation of duration, hypertension and glycemic control with microvascular complications of diabetes mellitus at a tertiary care hospital. Integr Mol Med. 2017;4(1). doi:10.15761/IMM.1000272
   Google Scholar
• Arambewela MH, Somasundaram NP, Jayasekara HBPR, et al. Prevalence of chronic complications, their risk factors, and the cardiovascular risk factors among patients with type 2 diabetes attending the diabetic clinic at a Tertiary Care Hospital in Sri Lanka. J Diabetes Res. 2018;2018:4504287. doi:10.1155/2018/4504287
   PubMed Web of Science ®Google Scholar
• Statistical Center of Iran > Population and Housing Censuses. Available from: https://www.amar.org.ir/english/Population-and-Housing-Censuses. Accessed September 23, 2019.
   Google Scholar
• McEwen LN, Kim C, Karter AJ, et al. Risk factors for mortality among patients with diabetes: the translating research into action for diabetes (TRIAD) Study. Diabetes Care. 2007;30(7):1736–1741. doi:10.2337/dc07-0305
   PubMed Web of Science ®Google Scholar
• Han SJ, Boyko EJ. The evidence for an obesity paradox in type 2 diabetes mellitus. Diabetes Metab J. 2018;42(3):179–187. doi:10.4093/dmj.2018.0055
   PubMedGoogle Scholar
• Liu H, Wu S, Li Y, et al. Body mass index and mortality in patients with type 2 diabetes mellitus: a prospective cohort study of 11,449 participants. J Diabetes Complications. 2017;31(2):328–333. doi:10.1016/j.jdiacomp.2016.10.015
   PubMed Web of Science ®Google Scholar
• Zoungas S, Woodward M, Li Q, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57(12):2465–2474. doi:10.1007/s00125-014-3369-7
   PubMed Web of Science ®Google Scholar
• van Hecke MV, Dekker JM, Stehouwer CDA, et al. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care. 2005;28(6):1383–1389. doi:10.2337/diacare.28.6.1383
   PubMed Web of Science ®Google Scholar
• Farkhondeh T, Samarghandian S, Roshanravan B. Impact of chrysin on the molecular mechanisms underlying diabetic complications. J Cell Physiol. 2019;234(10):17144–17158. doi:10.1002/jcp.28488
   PubMedGoogle Scholar
• Zhu X-R, Zhang Y-P, Bai L, Zhang X-L, Zhou J-B, Yang J-K. Prediction of risk of diabetic retinopathy for all-cause mortality, stroke and heart failure: evidence from epidemiological observational studies. Medicine. 2017;96(3).
   Google Scholar